Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 24, 2024 3:09 PM 2 min read

Lam Research Positioned For Growth Amid NAND Recovery And Advanced Packaging Strength, Analysts Highlight China Risks

by Nabaparna Bhattacharya Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

BofA Securities analyst Vivek Arya reiterated the Buy rating on Lam Research (NASDAQ:LRCX), raising the price forecast to $92 from $88.

Arya expresses confidence in Lam Research’s leverage to key tech trends, its strong exposure to a NAND recovery, and solid free cash flow generation.

However, the analyst notes that while China is expected to normalize to 30% of the mix in December, ongoing risks from export controls remain, and gains in gross and operating margins appear limited.

The analyst raises the earnings estimates for 2025 and 2026 by 4% and 7%, respectively.

The analyst writes that the company’s unique portfolio will help it outperform its competitors in 2025, despite concerns about ASML Holding N.V outlook.

Also Read: ASML Stock Plunges Further On Lower 2025 Sales Outlook: Analysts Break Down Semiconductor Challenges

Arya notes that recent high shipments of lithography tools to China might lead to a bigger correction there, but Lam Research is less affected by this due to its strengths in advanced technologies like NAND and packaging.

Overall, Lam Research has several growth opportunities in 2025, even with potential challenges in China and delays from Intel and Samsung.

Meanwhile, Goldman Sachs analyst Toshiya Hari reiterated the Buy rating on Lam Research, lowering the price forecast to $96 from $102.50).

The analyst highlights that advancements in NAND, leading-edge foundry/logic, and DRAM will increase demand for etching and deposition, helping Lam gain market share in wafer fabrication equipment (WFE) in 2025 and beyond.

The analyst notes that while ASML lowered its 2025 revenue guidance due to weak demand in leading-edge foundry and potential declines in Chinese spending, Lam Research maintained its forecast of a mid-$90 billion WFE market for 2024.

In fact, Lam Research expects WFE spending to grow in 2025, driven by changes in NAND technology and ongoing strength in DRAM, HBM, and leading-edge foundry sectors, the analyst adds.

Hari notes, Advanced Packaging, essential for AI technology, will boost Lam Research’s performance.

Additionally, in the Systems business, China’s share of total revenue decreased to 37% in the September quarter from 42% in the March quarter and 39% in the June quarter.

Per Hari, the market will perceive the guided decline in China contribution positively, given the tendency for the market to pay a below-average multiple for revenue streams generated in China.

According to Hari, the market is likely to view the expected decline in China’s contribution positively, as it typically assigns a “below-average” multiple to revenue generated in China.

Price Action: LRCX shares are trading higher by 4.87% to $76.41 at last check Thursday.

Photo via Shutterstock

Read Next:

  • Lucid CEO Throws Cold Water On Tesla’s Robotaxi Vision, Says Self-Driving Cars Won’t Happen ‘Till The 2030s’
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert IdeasStories That Matter
LRCX Logo
LRCXLam Research Corp
$209.33-0.08%
Overview
ASML Logo
ASMLASML Holding NV
$1348.76-0.21%
INTC Logo
INTCIntel Corp
$45.18-0.15%
LRCX Logo
LRCXLam Research Corp
$209.33-0.08%
Overview
ASML Logo
ASMLASML Holding NV
$1348.76-0.21%
INTC Logo
INTCIntel Corp
$45.18-0.15%
Comments
Loading...